Tasisulam sodium T40596

Product Introduction
Bioactivity


英文名: Tasisulam sodium

描述: Tasisulam is an anti-cancer compound that induces apoptosis through the intrinsic pathway, leading to the release of cytochrome c and caspase-dependent cell death. Additionally, tasisulam inhibits mitotic progression and triggers vascular normalization.

体外活性: Tasisulam sodium (200 nM-200 μM; 48 hours) induces an antiproliferative response across a wide range of tumor histologies with EC 50 s of 10 μM and 25 μM for Calu-6 and A-375 cell lines, respectively[1]. Tasisulam sodium (25, 50 μM; 72 hours) induces a concentration-dependent increase in 4N DNA and G2-M accumulation[1]. Tasisulam sodium (200 nM-200 μM; 48 hours) induces apoptosis in a broad range of in vitro cancer cell models[1]. Tasisulam sodium also blocks VEGF, epidermal growth factor, and fibroblast growth factor-induced endothelial cell cord formation[1]. Cell Proliferation Assay[1]Cell Line: Calu-6 non-small cell lung carcinoma and A-375 melanoma models Concentration: 200 nM-200 μM Incubation Time: 48 hours Result: Induced an antiproliferative response across a wide range of tumor histologies with EC 50 s is 10 μM and 25 μM, respectively. Cell Cycle Analysis[1]Cell Line: Calu-6 and A-375 cell lines Concentration: 25, 50 μM Incubation Time: 72 hours Result: Induced a concentration-dependent increase in 4N DNA and G2-M accumulation. Apoptosis Analysis[1]Cell Line: Calu-6 non-small cell lung carcinoma and A-375 melanoma models Concentration: 200 nM-200 μM Incubation Time: 48 hours Result: Induced apoptosis in a broad range of in vitro cancer cell models.

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

Tasisulam sodium T40596信息由TargetMol中国为您提供，如您想了解更多关于Tasisulam sodium T40596报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途